Last reviewed · How we verify
ClinOleic + Omegaven
ClinOleic + Omegaven is a combination intravenous lipid emulsion that provides essential fatty acids and omega-3 fatty acids for parenteral nutrition support.
ClinOleic + Omegaven is a combination intravenous lipid emulsion that provides essential fatty acids and omega-3 fatty acids for parenteral nutrition support. Used for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Nutritional support in critically ill patients, particularly those at risk of lipid-related complications.
At a glance
| Generic name | ClinOleic + Omegaven |
|---|---|
| Also known as | ClinOleic 20% Baxter + Omegaven 10% Fresenius Kabi |
| Sponsor | General University Hospital, Prague |
| Drug class | Intravenous lipid emulsion |
| Modality | Small molecule |
| Therapeutic area | Nutrition support / Critical care |
| Phase | FDA-approved |
Mechanism of action
ClinOleic is a mixed lipid emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil that provides balanced essential fatty acids and energy. Omegaven is a fish oil-based lipid emulsion rich in omega-3 polyunsaturated fatty acids (EPA and DHA). Together, they support nutritional requirements in patients unable to receive adequate oral or enteral nutrition, while the omega-3 component may help reduce inflammatory responses and support immune function.
Approved indications
- Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition
- Nutritional support in critically ill patients, particularly those at risk of lipid-related complications
Common side effects
- Hypertriglyceridemia
- Infusion site reactions
- Hepatic dysfunction
- Thrombocytopenia
Key clinical trials
- Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure (NA)
- Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ClinOleic + Omegaven CI brief — competitive landscape report
- ClinOleic + Omegaven updates RSS · CI watch RSS
- General University Hospital, Prague portfolio CI